A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Clinical trial NCT05403450 · TERMINATED
Trial details
- NCT number
- NCT05403450
- Sponsor
- Taiho Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2024-12-16
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.